Galati, D.; Zanotta, S.; Florio, F.; Mele, S.; De Filippi, R.; Pinto, A.
Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm. Int. J. Mol. Sci. 2025, 26, 2732.
https://doi.org/10.3390/ijms26062732
AMA Style
Galati D, Zanotta S, Florio F, Mele S, De Filippi R, Pinto A.
Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm. International Journal of Molecular Sciences. 2025; 26(6):2732.
https://doi.org/10.3390/ijms26062732
Chicago/Turabian Style
Galati, Domenico, Serena Zanotta, Fabrizia Florio, Sara Mele, Rosaria De Filippi, and Antonio Pinto.
2025. "Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm" International Journal of Molecular Sciences 26, no. 6: 2732.
https://doi.org/10.3390/ijms26062732
APA Style
Galati, D., Zanotta, S., Florio, F., Mele, S., De Filippi, R., & Pinto, A.
(2025). Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm. International Journal of Molecular Sciences, 26(6), 2732.
https://doi.org/10.3390/ijms26062732
